Insider Transactions in Q1 2023 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,506
-0.43%
|
$10,518
$3.16 P/Share
|
|
Mar 01
2023
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
6,878
-4.5%
|
$20,634
$3.03 P/Share
|
|
Mar 01
2023
|
Stephen Mitchener SVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
6,357
-4.72%
|
$19,071
$3.03 P/Share
|
|
Mar 01
2023
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
11,205
-4.37%
|
$33,615
$3.03 P/Share
|
|
Mar 01
2023
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11,239
-5.06%
|
$33,717
$3.03 P/Share
|
|
Mar 01
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
33,033
-3.86%
|
$99,099
$3.03 P/Share
|
|
Feb 28
2023
|
Reshma Rangwala EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+37.74%
|
-
|
|
Feb 28
2023
|
Michael Mano SVP, General Counsel&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+31.39%
|
-
|
|
Feb 28
2023
|
Stephen Mitchener SVP, Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+30.82%
|
-
|
|
Feb 28
2023
|
Stuart Poulton EVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
95,000
+37.38%
|
-
|
|
Feb 28
2023
|
Michael Mason EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
95,000
+27.02%
|
-
|
|
Feb 28
2023
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+31.06%
|
-
|
|
Feb 28
2023
|
Richard A. Paulson President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
252,000
+22.73%
|
-
|
|
Feb 27
2023
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,802
-1.7%
|
$8,406
$3.04 P/Share
|
|
Feb 15
2023
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,869
-2.8%
|
$17,607
$3.19 P/Share
|
|
Feb 06
2023
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
4,141
-2.46%
|
$12,423
$3.4 P/Share
|
|
Feb 06
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,950
-0.65%
|
$11,850
$3.4 P/Share
|
|
Jan 04
2023
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,922
-0.64%
|
$11,766
$3.27 P/Share
|